semaglutide south africa Product pulled from shelves in due to severe safety risks – BusinessTech South African pharmacy group iDexis

SKU: 84219776193

Pay in 4 interest-free payments of $6.84 Learn more

Live Spec

South African pharmacy group iDexis said on Tuesday it had applied to appeal a court judgment that curbed its production of compounded weight loss medicines, disputing allegations about product safety and regulatory compliance. # South Africa's High Court has granted Novo Nordisk an interim interdict barring a local pharmacy group from manufacturing and selling compounded weight loss medicines containing semaglutide, in a ruling that shows tightening scrutiny Novo's Ozempic copy 15% cheaper, but Discovery still won't change its position A South African court has ordered pharmacy group iDexis to stop selling semaglutide based medicines. The ruling follows a legal challenge by Novo Nordisk, maker of Ozempic and Wegovy. Novo alleged the company

Store: www.parrocchiaolginate.it · Domain: www.parrocchiaolginate.it